Taro Recalls Lidocaine Ointment for Failed Content Uniformity Specifications
Taro Pharmaceuticals is recalling Lidocaine Ointment 5% due to failed content uniformity specifications during stability testing.
- Product
- LIDOCAINE — LIDOCAINE (LIDOCAINE)
- Category
- Drug
- Distribution
- Distributed nationwide